Cargando…
Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase
The efficacy of treatments for diabetes mellitus-induced erectile dysfunction (DMED) is quite poor, and stem cell therapy is emerging as a useful method. In this study, we used endothelial progenitor cells (EPCs) overexpressing human telomerase reverse transcriptase (hTERT) for the treatment of DMED...
Autores principales: | Zhang, Yan, Chen, Zhi, Wang, Tao, Yang, Jun, Li, Rui, Wang, Shaogang, Liu, Jihong, Ye, Zhangqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129934/ https://www.ncbi.nlm.nih.gov/pubmed/27283992 http://dx.doi.org/10.18632/oncotarget.9909 |
Ejemplares similares
-
AB157. Treatment of diabetic erectile dysfunction by using endothelial progenitor cells genetically modified by human telomerase reverse transcriptase
por: Zhang, Yan, et al.
Publicado: (2015) -
Influence of Human Telomerase Reverse Transcriptase Mutation on the Aggressiveness and Recurrence in Meningiomas
por: Sahin, Balkan, et al.
Publicado: (2021) -
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
por: Lantuejoul, S, et al.
Publicado: (2004) -
Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023) -
AB195. Role of PI3K/AKT in the erectile dysfunction from metabolic syndrome rats
por: Li, Rui, et al.
Publicado: (2015)